Exact Mass: 460.308962
Exact Mass Matches: 460.308962
Found 500 metabolites which its exact mass value is equals to given mass value 460.308962,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
ST 27:4;O6
Same as: D09796
Lucidenic acid N
Lucidenic acid N is found in mushrooms. Lucidenic acid N is a constituent of Ganoderma lucidum (reishi).
Polyporusterone D
Polyporusterone D is found in mushrooms. Polyporusterone D is a constituent of Polyporus umbellatus (zhu ling). Constituent of Polyporus umbellatus (zhu ling). Polyporusterone D is found in mushrooms.
2,3-Secoporrigenin
(6beta,25S)-2,3-Secospirostan-3,6-olid-2-oic acid is found in onion-family vegetables. (6beta,25S)-2,3-Secospirostan-3,6-olid-2-oic acid is a constituent of Allium porrum (leek)
Polyporusterone E
Polyporusterone E is found in mushrooms. Polyporusterone E is a constituent of Polyporus umbellatus (zhu ling). Constituent of Polyporus umbellatus (zhu ling). Polyporusterone E is found in mushrooms.
(3beta,5alpha,9alpha,14alpha,22E,24R)-3,5,9,14-Tetrahydroxyergosta-7,22-dien-6-one
(3beta,5alpha,9alpha,14beta,22E,24R)-3,5,9,14-Tetrahydroxyergosta-7,22-dien-6-one is found in mushrooms. (3beta,5alpha,9alpha,14beta,22E,24R)-3,5,9,14-Tetrahydroxyergosta-7,22-dien-6-one is a constituent of Tricholoma matsutake (matsutake).
Polyporusterone G
Polyporusterone G is found in mushrooms. Polyporusterone G is a constituent of Polyporus umbellatus (zhu ling). Constituent of Polyporus umbellatus (zhu ling). Polyporusterone G is found in mushrooms.
all-trans-Carophyll yellow
Colour additive for foods, e.g. egg yolks. Colour additive for foods, e.g. egg yolks
N-Arachidonoyl Arginine
C26H44N4O3 (460.34132339999996)
N-arachidonoyl arginine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Arginine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Arginine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Arginine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Food orange 7
Menatetrenone Epoxide
Milciclib
C25H32N8O (460.26989419999995)
Petrosaspongiolide m
DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)
DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))
DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)
DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))
DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)
DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))
DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)
DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))
DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)
DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))
DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Lucidenic acid N
Lucidenic acid N is a tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. It has a role as a metabolite, an EC 3.1.1.8 (cholinesterase) inhibitor and an antineoplastic agent. It is a tetracyclic triterpenoid, a cyclic terpene ketone, a dioxo monocarboxylic acid and a secondary alcohol. Lucidenic acid N is a natural product found in Ganoderma lucidum and Bos taurus with data available. A tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. Constituent of Ganoderma lucidum (reishi). Lucidenic acid N is found in mushrooms.
12beta,20-Dihydroxy-16beta-Acetoxy-17-scalaren-19,20-olide
Milciclib
C25H32N8O (460.26989419999995)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
1-O-17-Methylstearylmyoinosit|1-O-17-Methylstearylmyrinosit
{(Z)-3-(chloromethylene)-2,3-dihydrobenzo[b]oxepin-7-yl}methyl palmitate
(25S)-3beta,4beta,6alpha,26-tetrahydroxy-24-methyl-5alpha-cholesta-8(14),24(241)-dien-15-one|certonardosterol Q5
2-Propyl-8-hydroxymethyl-12,14-dimethyl-15-benzyl-1-oxa-7,14-diazacyclohexadecane-6,13,16-trione
C26H40N2O5 (460.29370700000004)
5alpha,6alpha-epoxy-3beta,8beta,14alpha-trihydroxy-5alpha-ergosta-22E-en-7-one
(22E)-11-acetoxy-3beta,6alpha-dihydroxy-24-nor-9,11-seco-5alpha-cholesta-7,22-dien-9-one
2-O-[(3R,7R)-3-(acetyloxy)-7-hydroxyeicosanoyl]glycerol
namogenin C|spirosta-5,25(27)-dien-1beta,3beta,14alpha,17alpha-tetrol
3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one
2-O-[(3R,9R)-3-(acetyloxy)-9-hydroxyeicosanoyl]glycerol
polyporusterone G
(alpha5R,2R,5S,3E,7E)-alpha5-<9-(5-hydroxy-2-methoxy-3-methylphenyl)-3,7-dimethylnona-3,7-dienyl>-alpha2,alpha2,5-trimethyltetrahydrofuran-2,5-dimethanol
3alpha,9beta,13alpha-trihydroxy-11(12),15(17)-trinervitadiene propionate diacetate
spirosta-5,25(27)-diene-1beta,2alpha,3beta,12beta-tetrol
(22E)-3,5,6,7-tetrahydroxyergosta-8,22-dien-15-one|penicillisterol
1alpha,3beta,4beta-trihydroxy-24,30-dinorolean-6-ene-28-oic acid
2-O-[(3R,8R)-3-(acetyloxy)-8-hydroxyeicosanoyl]glycerol
2-O-[(3R,6S)-3-(acetyloxy)-6-hydroxyeicosanoyl]glycerol
6-Angeloyl,7-Ac-6,7-Dihydroxy-3,13-clerodadien-15-oic acid
7beta-hydroxy-11-oxo-3,4-seco-25,26,27-trinorlanosta-4(28),8-dien-3,24-dioic acid|fornicatin B
12-amino-9-sec-butyl-6-(1-hydroxy-1-methyl-propyl)-15-methoxy-4,7,10-triaza-bicyclo[12.3.1]octadeca-1(18),2,14,16-tetraene-5,8,11-trione|Zizyphine E|Zizyphine-E
(12alpha,25xi)-24,25-Epoxy-24-methyl-16-scalarene-12,22,25-triol
3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one
(1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24,25,28-pentol
24-methylene-1alpha,3beta,11alpha-trihydroxycholest-5-en-18-oic acid|24-methylene-1alpha,3beta,11alpha-trihydroxycholest-5en-18-oic acid
12alpha-acetoxy-16beta-hydroxy-24-methyl-24-oxoscalaran-25-al
Eicosapentaenoyl Serotonin
Ser Arg Ala Lys
3β,7β,15β-Trihydroxy-11-oxo-lanosta-8-en-24→20 lactone
7,15-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8-en-24-oic acid
Ala Lys Arg Ser
Ala Lys Ser Arg
Ala Arg Lys Ser
Ala Arg Ser Lys
Ala Ser Lys Arg
Ala Ser Arg Lys
Cys Ile Ile Ile
C21H40N4O5S (460.27192700000006)
Cys Ile Ile Leu
C21H40N4O5S (460.27192700000006)
Cys Ile Leu Ile
C21H40N4O5S (460.27192700000006)
Cys Ile Leu Leu
C21H40N4O5S (460.27192700000006)
Cys Leu Ile Ile
C21H40N4O5S (460.27192700000006)
Cys Leu Ile Leu
C21H40N4O5S (460.27192700000006)
Cys Leu Leu Ile
C21H40N4O5S (460.27192700000006)
Cys Leu Leu Leu
C21H40N4O5S (460.27192700000006)
Phe Pro Val Val
Phe Val Pro Val
Phe Val Val Pro
Gly Lys Arg Thr
Gly Lys Thr Arg
Gly Arg Lys Thr
Gly Arg Thr Lys
Gly Thr Lys Arg
Gly Thr Arg Lys
Ile Cys Ile Ile
C21H40N4O5S (460.27192700000006)
Ile Cys Ile Leu
C21H40N4O5S (460.27192700000006)
Ile Cys Leu Ile
C21H40N4O5S (460.27192700000006)
Ile Cys Leu Leu
C21H40N4O5S (460.27192700000006)
Ile Ile Cys Ile
C21H40N4O5S (460.27192700000006)
Ile Ile Cys Leu
C21H40N4O5S (460.27192700000006)
Ile Ile Ile Cys
C21H40N4O5S (460.27192700000006)
Ile Ile Leu Cys
C21H40N4O5S (460.27192700000006)
Ile Leu Cys Ile
C21H40N4O5S (460.27192700000006)
Ile Leu Cys Leu
C21H40N4O5S (460.27192700000006)
Ile Leu Ile Cys
C21H40N4O5S (460.27192700000006)
Ile Leu Leu Cys
C21H40N4O5S (460.27192700000006)
Ile Met Val Val
C21H40N4O5S (460.27192700000006)
Ile Val Met Val
C21H40N4O5S (460.27192700000006)
Ile Val Val Met
C21H40N4O5S (460.27192700000006)
Lys Ala Arg Ser
Lys Ala Ser Arg
Lys Gly Arg Thr
Lys Gly Thr Arg
Lys Lys Ser Val
Lys Lys Val Ser
Lys Arg Ala Ser
Lys Arg Gly Thr
Lys Arg Ser Ala
Lys Arg Thr Gly
Lys Ser Ala Arg
Lys Ser Lys Val
Lys Ser Arg Ala
Lys Ser Val Lys
Lys Thr Gly Arg
Lys Thr Arg Gly
Lys Val Lys Ser
Lys Val Ser Lys
Leu Cys Ile Ile
C21H40N4O5S (460.27192700000006)
Leu Cys Ile Leu
C21H40N4O5S (460.27192700000006)
Leu Cys Leu Ile
C21H40N4O5S (460.27192700000006)
Leu Cys Leu Leu
C21H40N4O5S (460.27192700000006)
Leu Ile Cys Ile
C21H40N4O5S (460.27192700000006)
Leu Ile Cys Leu
C21H40N4O5S (460.27192700000006)
Leu Ile Ile Cys
C21H40N4O5S (460.27192700000006)
Leu Ile Leu Cys
C21H40N4O5S (460.27192700000006)
Leu Leu Cys Ile
C21H40N4O5S (460.27192700000006)
Leu Leu Cys Leu
C21H40N4O5S (460.27192700000006)
Leu Leu Ile Cys
C21H40N4O5S (460.27192700000006)
Leu Leu Leu Cys
C21H40N4O5S (460.27192700000006)
Leu Met Val Val
C21H40N4O5S (460.27192700000006)
Leu Val Met Val
C21H40N4O5S (460.27192700000006)
Leu Val Val Met
C21H40N4O5S (460.27192700000006)
Met Ile Val Val
C21H40N4O5S (460.27192700000006)
Met Leu Val Val
C21H40N4O5S (460.27192700000006)
Met Val Ile Val
C21H40N4O5S (460.27192700000006)
Met Val Leu Val
C21H40N4O5S (460.27192700000006)
Met Val Val Ile
C21H40N4O5S (460.27192700000006)
Met Val Val Leu
C21H40N4O5S (460.27192700000006)
Pro Phe Val Val
Pro Val Phe Val
Arg Ala Lys Ser
Arg Ala Ser Lys
Arg Gly Lys Thr
Arg Gly Thr Lys
Arg Lys Ala Ser
Arg Lys Gly Thr
Arg Lys Ser Ala
Arg Lys Thr Gly
Arg Ser Ala Lys
Arg Ser Lys Ala
Arg Thr Gly Lys
Arg Thr Lys Gly
Ser Ala Lys Arg
Ser Ala Arg Lys
Ser Lys Ala Arg
Ser Lys Lys Val
Ser Lys Arg Ala
Ser Lys Val Lys
Ser Arg Lys Ala
Ser Val Lys Lys
Thr Gly Lys Arg
Thr Gly Arg Lys
Thr Lys Gly Arg
Thr Lys Arg Gly
Thr Arg Gly Lys
Thr Arg Lys Gly
Val Ile Met Val
C21H40N4O5S (460.27192700000006)
Val Ile Val Met
C21H40N4O5S (460.27192700000006)
Val Lys Lys Ser
Val Lys Ser Lys
Val Leu Met Val
C21H40N4O5S (460.27192700000006)
Val Leu Val Met
C21H40N4O5S (460.27192700000006)
Val Met Ile Val
C21H40N4O5S (460.27192700000006)
Val Met Leu Val
C21H40N4O5S (460.27192700000006)
Val Met Val Ile
C21H40N4O5S (460.27192700000006)
Val Met Val Leu
C21H40N4O5S (460.27192700000006)
Val Ser Lys Lys
Val Val Ile Met
C21H40N4O5S (460.27192700000006)
Val Val Leu Met
C21H40N4O5S (460.27192700000006)
Val Val Met Ile
C21H40N4O5S (460.27192700000006)
Val Val Met Leu
C21H40N4O5S (460.27192700000006)
(6R)-vitamin D2 6,19-sulfur dioxide adduct / (6R)-ergocalciferol 6,19-sulfur dioxide adduct
(6S)-vitamin D2 6,19-sulfur dioxide adduct / (6S)-ergocalciferol 6,19-sulfur dioxide adduct
(24R)-1α,24,25,26-tetrahydroxyvitamin D2 / (24R)-1α,24,25,26-tetrahydroxyergocalciferol
1α,24,25,28-tetrahydroxyvitamin D2 / 1α,24,25,28-tetrahydroxyergocalciferol
24-Nor-9,11-seco-11-acetoxy-3,6-dihydroxycholest-7,22-dien-9-one
2,3-Secoporrigenin
(3beta,5alpha,9alpha,14alpha,22E,24R)-3,5,9,14-Tetrahydroxyergosta-7,22-dien-6-one
FOOD Orange 7
Polyporusterone E
Polyporusterone D
bhas#34
An (omega-1)-hydroxy fatty acid ascaroside that is ascr#34 in which the pro-R hydrogen that is beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
bhos#34
An omega-hydroxy fatty acid ascaroside that is oscr#34 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
Strophasterol E
Strophasterol F
(6R)-vitamin D2 6,19-sulfur dioxide adduct
(6S)-vitamin D2 6,19-sulfur dioxide adduct
(24R)-1alpha,24,25,26-tetrahydroxyvitamin D2
1alpha,24,25,28-tetrahydroxyvitamin D2
Omega-hydroxymenaquinone-4
A prenylnaphthoquinone obtained by hydroxylation of one of the terminal methyl groups of menaquinone-4.
6b-Hydroxymethandienone
C26H44O3Si2 (460.28288339999995)
6b-Hydroxymethandienone is a metabolite of the androgen metandienone metabolite, excreted in the urine. Metandienone has been used in horse doping and by weightlifters and body builders. It is of note to consider that the use of anabolic steroids for an extended period of time reduces the excretion of endogenous metabolites, making the detection of doping a little more difficult. (PMID: 16040239, 757586, 9001954, 2745643, 12375280, 8539789, 1400752, 757586, 17610244) [HMDB]
POLY(DIMETHYLSILOXANE), DISTEARATE TERMINATED
C26H52O2S2 (460.34085319999997)
1,1-[Oxybis(methylene-4,1-phenyleneoxy)]bis[3-(isopropylamino)-2-propanol]
C26H40N2O5 (460.29370700000004)
H-Lys-Trp-Lys-OH
H-Lys-Trp-Lys-OH is a small molecule peptide which displays antibacterial and antiviral activities extracted from patent CN 104072579 A, Compound AMP12.
(3R)-19-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxynonadecanoic acid
(3R,18R)-18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxynonadecanoic acid
Ergosta-7,20-dien-6-one, 2,3,14,22-tetrahydroxy-, (2beta,3beta,5beta,22R)-
Ergost-7-en-6-one, 22,23-epoxy-2,3,14-trihydroxy-, (2beta,3beta,5beta,22S,23S)-
(2beta,3beta,5beta,22R)-2,3,14,22-Tetrahydroxyergosta-7,24(28)-dien-6-one
(24R)-1alpha,24,25,26-tetrahydroxyvitamin D2/(24R)-1alpha,24,25,26-tetrahydroxyergocalciferol
1alpha,24,25,28-tetrahydroxyvitamin D2/1alpha,24,25,28-tetrahydroxyergocalciferol
[3-carboxy-2-[(E)-7-[(5Z)-5-[(E)-oct-2-enylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxypropyl]-trimethylazanium
C27H42NO5+ (460.30628220000006)
3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
1-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-[(4S,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4S,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
[(4E,8E,12E)-2-acetamido-3-hydroxypentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C22H41N2O6P (460.27020960000004)
[3-carboxy-2-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxypropyl]-trimethylazanium
C28H46NO4+ (460.34266560000003)
[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C22H41N2O6P (460.27020960000004)
(1-hydroxy-3-propanoyloxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
(1-hydroxy-3-pentanoyloxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
(1-heptanoyloxy-3-hydroxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[3-(3-Acetyloxy-2-dodecanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium
[1-Carboxy-3-(3-propanoyloxy-2-undecanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(3-hexanoyloxy-2-octanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(2-nonanoyloxy-3-pentanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-[2,3-di(heptanoyloxy)propoxy]propyl]-trimethylazanium
[3-(3-Butanoyloxy-2-decanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium
2-[carboxy-[2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
3beta,6alpha-dihydroxy-11-acetoxy-24-nor-9,11-seco-cholest-7,22E-diene-9-one
(7E)-(3S,6R)-6,19-epithio-9,10-seco-5(10),7,22-ergostatrien-3-ol S,S-dioxide
2,3-epoxymenatetrenone
A member of the class of tetralins obtained by formal epoxidation across the 2,3-double bond of menatetrenone.
TG(24:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
5,8,11,15-tetramethyl-4-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-12-yl octanoate
2-[(1s,2r,5r)-2-[(4s,4as,6s,8as)-4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl]-1-methyl-5-[(2r,3e)-5-methylhex-3-en-2-yl]cyclopentyl]ethyl acetate
2-[(1r,2r,5r)-2-[(4s,4as,6s,8as)-4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl]-1-methyl-5-[(2r,3e)-5-methylhex-3-en-2-yl]cyclopentyl]ethyl acetate
(1r,2r,4r,5s,8r,13s,14s,17s,18r,20r)-5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate
1,3-dihydroxypropan-2-yl 3-(acetyloxy)-9-hydroxyicosanoate
(3s,4ar,6ar,8s,10r,10ar,10bs)-8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl (2z)-2-methylbut-2-enoate
(1r,3r,5as,5br,7as,11ar,11br,13s,13as,13bs)-1-hydroxy-11a-(hydroxymethyl)-3,5b,8,8,13a-pentamethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-13-yl acetate
(1r,5s,5as,6r,7s,9ar,9br,11ar)-5,6,7-trihydroxy-1-[(2r,6s)-7-hydroxy-6-methyl-5-methylideneheptan-2-yl]-9a,11a-dimethyl-1h,2h,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-one
2-[2-(4-methoxy-4-methylpent-2-en-1-yl)-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
(1e)-2-[(4r,5s,7s,8s)-8-(hydroxymethyl)-7,8-dimethoxy-2,5-dimethyl-5-(4-methylpent-3-en-1-yl)-4h,6h,7h-cyclohepta[b]furan-4-yl]ethenyl 3-methylbut-2-enoate
(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16'r,18's,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione
4-hydroxy-2-methyl-5-[(14z)-nonadec-14-en-1-yl]-3,6-dioxocyclohexa-1,4-dien-1-yl acetate
8-[6-(acetyloxy)-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-6-methyl-2-(4-methylpentyl)octanoic acid
1,3-dihydroxypropan-2-yl (3r,8r)-3-(acetyloxy)-8-hydroxyicosanoate
(2s,3as,5s)-3a-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-2-(2-hydroxypropan-2-yl)-5-methyl-7-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-4,6-dione
3β,5α,9α,14β-tetrahydroxy-(22e)-ergosta-7,22-dien-6-one
{"Ingredient_id": "HBIN008091","Ingredient_name": "3\u03b2,5\u03b1,9\u03b1,14\u03b2-tetrahydroxy-(22e)-ergosta-7,22-dien-6-one","Alias": "NA","Ingredient_formula": "C28H44O5","Ingredient_Smile": "CC(C)C(C)C=CC(C)C1CCC2(C1(CCC3(C2=CC(=O)C4(C3(CCC(C4)O)C)O)O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21090","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate
(1r,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-trihydroxy-9a,11a-dimethyl-1-[(1s)-1-[(2s,3s)-3-[(2r)-3-methylbutan-2-yl]oxiran-2-yl]ethyl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate
(1z)-2-[(1s,3s,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
2-[2-(4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl)-1-methyl-5-(5-methylhex-3-en-2-yl)cyclopentyl]ethyl acetate
(1r,3as,4r,5s,5as,7s,9ar,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-4,5,5a,7-tetrahydroxy-9a,11a-dimethyl-1h,2h,3ah,4h,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-3-one
16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione
(1's,2s,2's,4s,4's,7'r,8'r,9's,12's,13's,16'r,18's)-7',16'-dihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-one
4-[6-(2-carboxyethyl)-9-hydroxy-3a,6,9b-trimethyl-5-oxo-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h,9h-cyclopenta[a]naphthalen-3-yl]pentanoic acid
2-[3-methoxy-11-(4-methoxy-4-methylpent-2-en-1-yl)-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
(1r,3as,3bs,4r,9ar,9bs,11ar)-4-hydroxy-9a,11a-dimethyl-1-[(2s,3r,5r)-3,5,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(3s,4as,6s)-4a-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3,6-dihydroxy-2,2,6-trimethyl-8-[(2r)-2-methylbutanoyl]-3,4-dihydro-1-benzopyran-5,7-dione
(4r)-4-[(1r,3ar,4s,5as,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid
3a,7-dihydroxy-1-[6-hydroxy-5-(hydroxymethyl)-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(1e)-2-[(1s,3r,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
(1's,3r,3ar,7's,9's,15as)-1',6,7',10,14-pentamethyl-3a,4,5,8,9,12,13,15a-octahydrospiro[cyclotetradeca[b]furan-3,10'-tricyclo[7.2.1.0²,⁸]dodecane]-2'(8'),3'-dien-2-one
12-{4-[2-(dimethylamino)ethyl]phenoxymethyl}-5-methyl-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadeca-6,12-dien-9-ol
(2s,3ar)-4-hydroxy-7-{[(1r,2s,5r)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-6-one
[3-(chloromethylidene)-2h-1-benzoxepin-7-yl]methyl hexadecanoate
8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 3-methylbut-2-enoate
3a,7,8-trihydroxy-1-(3-hydroxy-6-methyl-5-methylideneheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(2r,3as)-4-hydroxy-7-{[(1s,2r,5s)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-[(2s)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-6-one
[2-(2-hydroxy-5-oxo-2h-furan-3-yl)-3b,6,6,9a-tetramethyl-dodecahydrophenanthro[2,1-b]furan-11a-yl]methyl acetate
3',4,7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-(2-methylbutanoyl)-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione
4-hydroxy-7-{[2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-(2-methylbutanoyl)-2,3-dihydro-1-benzofuran-6-one
(1s,5r,8r,9r,11r,14s,17s,18s)-12-{4-[2-(dimethylamino)ethyl]phenoxymethyl}-5-methyl-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadeca-6,12-dien-9-ol
(1e)-2-[(1s,2s,7s)-2-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
(5r,7's,9's,13'r,16's,18's,19'r)-16',19'-dihydroxy-5,7',9',13',18'-pentamethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one
1-(5,6-dimethyl-3-oxoheptan-2-yl)-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
5,7',9',13'-tetramethyl-16'-oxo-5',17'-dioxaspiro[oxane-2,6'-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecan]-13'-ylacetic acid
(1s,2r,5r,6r,14r,16r)-n,n,6-trimethyl-5-[4-(3-methylpyridin-4-yl)butan-2-yl]-19-oxapentacyclo[14.2.1.0¹,⁹.0²,⁶.0¹¹,¹⁶]nonadeca-9,11-dien-14-amine
7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',8',14',16'-tetrol
(1e)-2-[(1s,3s,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
4-hydroxy-2-methyl-5-(nonadec-14-en-1-yl)-3,6-dioxocyclohexa-1,4-dien-1-yl acetate
(3s,4as,6s)-4a-(3,7-dimethylocta-2,6-dien-1-yl)-3,6-dihydroxy-2,2,6-trimethyl-8-[(2r)-2-methylbutanoyl]-3,4-dihydro-1-benzopyran-5,7-dione
(1r,3as,5as,7s,9ar,9br,11ar)-3a,7-dihydroxy-1-[(2r,3e,5r)-6-hydroxy-5-(hydroxymethyl)-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
1,3-dihydroxypropan-2-yl 3-(acetyloxy)-6-hydroxyicosanoate
(1r)-2-[(1r,2s,4as,4bs,8as,10as)-2-formyl-4b,8,8,10a-tetramethyl-decahydro-1h-phenanthren-1-yl]-1-(2-hydroxy-5-oxo-2h-furan-3-yl)ethyl acetate
(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16'r,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione
(1s,3r,4ar,4bs,6as,10as,10bs,12as)-3-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate
[(3z)-3-(chloromethylidene)-2h-1-benzoxepin-7-yl]methyl hexadecanoate
methyl 6'-(3-methoxy-3-oxopropyl)-2',3a,4,6',7-pentamethyl-6-oxo-5'-(prop-1-en-2-yl)-4,5-dihydro-3h-spiro[1-benzofuran-2,1'-cyclohexane]-5-carboxylate
(1r,3ar,5as,7s,9as,9bs,11ar)-7,9b-dihydroxy-1-[(2r,3e,5r)-6-hydroxy-5-(hydroxymethyl)-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-5-one
(1r,3as,3bs,7r,9s,9ar,9bs,10r,11as)-7,9,10-trihydroxy-9a-methyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid
(1r,3'r,3'as,5r,7's,7'as)-2,3',7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-[(2s)-2-methylbutanoyl]-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-2-ene-4,6-dione
(1s,2s,3r,4as,4br,6as,10as,10br,12s,12as)-2-acetyl-1-formyl-12-hydroxy-4b,7,7,10a,12a-pentamethyl-tetradecahydrochrysen-3-yl acetate
(1'r,2r,2'r,4's,7's,8's,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',8',14',16'-tetrol
7',16'-dihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-one
(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,14's,18'r)-5,7',9',13'-tetramethyl-16'-oxo-5',17'-dioxaspiro[oxane-2,6'-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecan]-13'-ylacetic acid
(1r,3ar,3br,4r,9as,9bs,11as)-4-hydroxy-9a,11a-dimethyl-1-[(2s,3r,5s)-3,5,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
2-[8-(hydroxymethyl)-7,8-dimethoxy-2,5-dimethyl-5-(4-methylpent-3-en-1-yl)-4h,6h,7h-cyclohepta[b]furan-4-yl]ethenyl 3-methylbut-2-enoate
(1s,3s,5s,6s,8r,9s,10s,13r,14s,17s,19r,21r)-5,14-dimethyl-5-(4-methyl-3-methylidenepentyl)-2,4-dioxahexacyclo[11.8.0.0¹,⁹.0³,¹⁰.0⁶,¹⁰.0¹⁴,¹⁹]henicosane-8,17,21-triol
(1r)-2-[(1r,2s,4as,4bs,8as,10as)-2-formyl-4b,8,8,10a-tetramethyl-decahydro-1h-phenanthren-1-yl]-1-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]ethyl acetate
4-hydroxy-9a,11a-dimethyl-1-(3,5,6-trihydroxy-5,6-dimethylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
n,n,6-trimethyl-5-[4-(3-methylpyridin-4-yl)butan-2-yl]-19-oxapentacyclo[14.2.1.0¹,⁹.0²,⁶.0¹¹,¹⁶]nonadeca-9,11-dien-14-amine
1',6,7',10,14-pentamethyl-3a,4,5,8,9,12,13,15a-octahydrospiro[cyclotetradeca[b]furan-3,10'-tricyclo[7.2.1.0²,⁸]dodecane]-2'(8'),3'-dien-2-one
(1r,3ar,3br,4r,9as,9bs,11as)-4-hydroxy-9a,11a-dimethyl-1-[(2s,3r,5r)-3,5,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
7,9,10-trihydroxy-9a-methyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid
(3r)-17-oxo-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}octadecanoic acid
4-{4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid
1-(5,6-dimethylhept-3-en-2-yl)-3a,5a,7,9b-tetrahydroxy-9a,11a-dimethyl-1h,2h,3h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-5-one
5,5a,8,10-tetrahydroxy-9a,11a-dimethyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-9-one
(1r)-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-19-hydroxy-3,7,12,16-tetramethylnonadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol
3a,7,8-trihydroxy-9a,11a-dimethyl-1-{1-[3-(3-methylbutan-2-yl)oxiran-2-yl]ethyl}-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
1,3-dihydroxypropan-2-yl (3r,9r)-3-(acetyloxy)-9-hydroxyicosanoate
(1s,2s,5r,6s,9s,11r,13s,14s,15s,16r,18s,20r)-6,20-dimethyl-20-(4-methyl-3-methylidenepentyl)-17,19-dioxahexacyclo[14.4.1.0²,¹⁵.0²,¹⁸.0⁵,¹⁴.0⁶,¹¹]henicosane-9,13,14-triol
(3s,10r)-3-benzyl-12-hydroxy-10-(hydroxymethyl)-4,6-dimethyl-16-propyl-1-oxa-4,11-diazacyclohexadec-11-ene-2,5-dione
C26H40N2O5 (460.29370700000004)